Jyothy Laboratories reported a good quarter. Margins have beaten estimates while EBITDA grew almost 37 percent, in fact, margins have improved despite lower gross margins and higher ad spends. In an interview to CNBC-TV18, Ullas Kamath, Joint MD of the company discussed the Q3 performance.
Kamath said that off take, post goods and services tax (GST), has improved.
He further said that household insecticides business will improve in Q4.
We are seeing strong growth in Margo brand, he added.
We expect margin to sustain between 15 percent and 16 percent for the next few quarters, he said.
Watch accompanying video for more details.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
